Partnering Opportunities

Assets available for co-development and licensing

Opportunities for orphan biosimilar candidates

Valerius is developing its orphan drug biosimilar candidates until market approval. We are seeking for biopharmaceutical companies as reliable strategic partners to support marketing and sales activities for our orphan biosimilar assets.

Opportunities for non-orphan biosimilar candidates

Valerius offers the opportunity of licensing non-orphan drug biosimilar candidates after proof-of-biosimilarity, based on comparative quality studies. We also remain open for other collaboration opportunities, e.g. co-developments, to support further non-clinical and clinical development of our non-orphan biosimilar assets.

We use cookies to improve your user experience. By continuing to browse the site you are giving your consent for us to set cookies. If you don't agree, you can find here further informations.

OK, I agree.